维普中文期刊产品整合服务
9篇 您的检索式:作者名="RIANE D"
    题名 作者 年代 出处 被引量
1DNA Repair by ERCC1 in non small-cell lung cancer and cisplatin-based adjuvant chemotherapy显示文摘KEN A OLAUSSEN RIANE D 2006NewEngland J Med2006,355,10:1
2Development of a-phase morphologies during low temperature isothermal heat treatment of a Ti-5AI-5Mo-SV-3Cr alloy 显示文摘AIiD M Rian J D 2011Materials Science and Engineer- ing A2011,528,:1
3Estimation of Fuel Moisture Content from Multitemporal Analysis of Landsat Thematic Mapper Reflectance Data:Applications in Fire Danger Assessment显示文摘Chuvieco E Rian D Aguado I 2001International Journal of Remote Sensing2001,23,11:1
4Large- eddy simulation of the flow over a circular cylinder at Reynolds number 3900 using the OpenFOAM tool- box显示文摘LYSENKO D A ERTESVAG I S RIAN K E 2012Flow Turbulence and Combustion2012,89,4:1
5Estimation of fuel moisture content from multitemporal analysis of Landsat Thematic Mapper refleetance data:applications in fire danger assessment显示文摘CHUVIEEO E RIAN D AGUADO I 0,,11:1
6Estimation of Fuel Moisture Content from Multitemporal Analysis of Landsat Thematic Mapper Reflectance Data:Applications in Fire Danger Assessment显示文摘Chuvieco E Rian D Aguado I 2001International Journal of Remote sensing2001,23,11:1
7Scheduling an operating theatre under human resource constraints显示文摘Roland B Martinelly C D Riane F 2010Computers & Industrial Engineering2010,58,2:1
8Large-Eddy Simulation of the flow over a circular cylinder at reynolds number 3900 using the open FOAM toolbox 显示文摘Lysenko D A Ertesvog I S Rian K E 2012Flow Turbulence Combust2012,89,:1
9Real-world disease activity and sociodemographic,clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil显示文摘BACKGROUND Understanding the treatment landscape of inflammatory bowel diseases(IBD)is essential for improving disease management and patient outcomes.Brazil is the largest Latin American country,and it presents socioeconomic and health care differences across its geographical regions.This country has the highest increase in IBD incidence and prevalence in Latin America,but information about the clinical and treatment characteristics of IBD is scarce.AIM To describe the sociodemographic,clinical,and treatment characteristics of IBD outpatients in Brazil overall and in the Southeast,South and Northeast/Midwest regions.METHODS Multicenter,cross-sectional study with a 3-year retrospective chart review component.Patients with moderate-to-severe Crohn’s disease(CD)or ulcerative colitis(UC)were consecutively enrolled between October 2016 and February 2017.Active CD at enrollment was defined as a Harvey Bradshaw Index≥8 or a CD Activity Index≥220 or a calprotectin level>200μg/g or an active result based on colonoscopy suggestive of inadequate control during the previous year;active UC was defined as a partial Mayo score≥5.Descriptive statistics were used to analyze all variables.RESULTS In a total of 407 included patients,CD was more frequent than UC,both overall(264 CD/143 UC patients)and by region(CD:UC ratios of 2.1 in the Southeast,1.6 in the South and 1.2 in the Northeast/Midwest).The majority of patients were female(54.2%of CD;56.6%of UC),and the mean ages were 45.9±13.8 years(CD)and 42.9±13.0 years(UC).The median disease duration was 10.0(range:0.5-45)years for both IBD types.At enrollment,44.7%[95%confidence interval(CI):38.7-50.7]of CD patients and 25.2%(95%CI:18.1-32.3)of UC patients presented with active disease.More than 95%of IBD patients were receiving treatment at enrollment;CD patients were commonly treated with biologics(71.6%)and immunosuppressors(67.4%),and UC patients were commonly treated with mesalazine[5-Aminosalicylic acid(5-ASA)]derivates(69.9%)and immunosuppressors(44.1%).More than 50%of the CD patients had ileocolonic disease,and 41.7%presented with stricturing disease.One-quarter of CD patients had undergone CD-related surgery in the past 3 years,and this proportion was lower in the Northeast/Midwest region(2.9%).CONCLUSION In Brazil,there are regional variations in IBD management.CD outweighs UC in both frequency and disease activity.However,one-quarter of UC patients have active disease,and most are receiving 5-ASA treatment.Cyrla Zaltman Rogério Serafim Parra Ligia Yukie Sassaki Genoile Oliveira Santana Maria de Lourdes Abreu Ferrari Sender J Miszputen Heda M B S Amarante Roberto Luiz Kaiser Junior Cristina Flores Wilson R Catapani JoséMiguel Luz Parente Mauro Bafutto Odery Ramos Carolina D Gonçalves Isabella Miranda Guimaraes Jose J R da Rocha Marley R Feitosa Omar Feres Rogerio Saad-Hossne Francisco Guilherme Cancela Penna Pedro Ferrari Sales Cunha Tarcia NF Gomes Rodrigo Bremer Nones Mikaell Alexandre Gouvea Faria Mírian Perpétua Palha Dias Parente António S Scotton Rosana Fusaro Caratin Juliana Senra Júlio Maria Chebli 2021World Journal of Gastroenterology2021,27,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费